REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto Caldense de Patologia I.C.P. S.A.S (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Instituto Caldense de Patologia I.C.P. S.A.S Profile Updated: August 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Instituto Caldense de Patologia I.C.P. S.A.S is based in Colombia. The head office is in Manizales. It operates in the Diagnostic Imaging Centers sector. It was first established on October 23, 1992. There are currently 20 (2024) people employed by Instituto Caldense de Patologia I.C.P. S.A.S. The latest financial highlights indicate a net sales revenue increase of 2.63% in 2023. During that time, Instituto Caldense de Patologia I.C.P. S.A.S’s total assets grew by 11.3%. The net profit margin of Instituto Caldense de Patologia I.C.P. S.A.S decreased by 0.46% in 2023.

Headquarters
Calle 55 Nro. 24-67
Manizales; Caldas;

Contact Details: Purchase the Instituto Caldense de Patologia I.C.P. S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Instituto Caldense de Patologia I.C.P. S.A.S report to view the information.
Outstanding Shares:
Purchase the Instituto Caldense de Patologia I.C.P. S.A.S report to view the information.
Incorporation Date:
October 23, 1992
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Instituto Caldense de Patologia I.C.P. S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
2.63%
Total operating revenue
2.63%
Operating profit (EBIT)
28.8%
EBITDA
36.79%
Net Profit (Loss) for the Period
-42.58%
Total assets
11.3%
Total equity
0.92%
Operating Profit Margin (ROS)
1.25%
Net Profit Margin
-0.46%
Return on Equity (ROE)
-0.73%
Debt to Equity Ratio
3.25%
Quick Ratio
-0.12%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?